|
Santa Cruz Biotechnology
anti pegfr Anti Pegfr, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pegfr+y1173/p-EGFR+Antibody/pmc10510759-121-4-14 Average 94 stars, based on 1 article reviews
anti pegfr - by Bioz Stars,
2026-09
94/100 stars
|
Buy from Supplier |
|
Cell Signaling Technology Inc
net gelatin against pegfr y1173 Net Gelatin Against Pegfr Y1173, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pegfr+y1173/Phospho-EGF+Receptor+(Tyr1173)+Rabbit+mAb/pmc04350329-169-9-13 Average 96 stars, based on 1 article reviews
net gelatin against pegfr y1173 - by Bioz Stars,
2026-09
96/100 stars
|
Buy from Supplier |
|
R&D Systems
phosphorylated egfr Phosphorylated Egfr, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pegfr+y1173/Human+Phospho-EGFR+(Y1173)+Antibody/10__1158_slash_1535___7163__mct___20___0071-41-23-25 Average 93 stars, based on 1 article reviews
phosphorylated egfr - by Bioz Stars,
2026-09
93/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
rabbit anti pegfr Rabbit Anti Pegfr, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pegfr+y1173/rabbit+anti-goat+IgG-HRP/us10017768-346-59-73 Average 96 stars, based on 1 article reviews
rabbit anti pegfr - by Bioz Stars,
2026-09
96/100 stars
|
Buy from Supplier |
|
Cell Signaling Technology Inc
anti pegfr Anti Pegfr, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pegfr+y1173/EGF+Receptor+Mouse+mAb/pmc06753061-159-5-10 Average 93 stars, based on 1 article reviews
anti pegfr - by Bioz Stars,
2026-09
93/100 stars
|
Buy from Supplier |
|
R&D Systems
pegfr Pegfr, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pegfr+y1173/Human+Phospho-EGFR+(Y1173)+Antibody/10__1158_slash_0008___5472__can___22___0394-80-18-21 Average 93 stars, based on 1 article reviews
pegfr - by Bioz Stars,
2026-09
93/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
antibodies against human phosphorylated egfr ![]() Antibodies Against Human Phosphorylated Egfr, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pegfr+y1173/EGFR/10__1158_slash_1078___0432__ccr___11___2825-69-10-17 Average 96 stars, based on 1 article reviews
antibodies against human phosphorylated egfr - by Bioz Stars,
2026-09
96/100 stars
|
Buy from Supplier |
|
Mouse monoclonal phospho EGFR antibody
|
Buy from Supplier |
Image Search Results
Journal: Clinical Cancer Research
Article Title: A Phase II Study of Lapatinib in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
doi: 10.1158/1078-0432.ccr-11-2825
Figure Lengend Snippet: Figure 1. Kaplan–Meier survival curves. Survival estimates of PFS and OS for patients who were EGFR naive (group A) and those with prior exposure to EGFR (group B).
Article Snippet: To measure potential target inhibition by lapatinib and downstream signaling,
Techniques:
Journal: Clinical Cancer Research
Article Title: A Phase II Study of Lapatinib in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
doi: 10.1158/1078-0432.ccr-11-2825
Figure Lengend Snippet: Figure 2. Ratio of MFI of selected biomarkers by LSC pre- and posttreatment with lapatinib. Posttreatment biopsies showed a significant decreased pERBB2/ ERBB2 (or pHER-2/HER-2) ratio when compared with pretreatment biopsies. Pre- and posttreatment pEGFR/EGFR ratios were not statistically different. Five patients were analyzed pre- and posttreatment. Nine patients were analyzed pretreatment. Stable disease was the best response in one patient.
Article Snippet: To measure potential target inhibition by lapatinib and downstream signaling,
Techniques: